Skip to content
Riskpilot
← Back to search
Sign in
Get full access
IMMUNOR AS
AS
Active
Org 914405920
Gaustadalléen 21, 0349
Oslo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2014 · 11 years old
0 employees
www.immunor.com
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
IMMUNOR AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AS
Andres Schjønhaug Susrud
Chief Executive Officer
Chief Executive Officer
2020
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
BS
Birger Sørensen
Chairman
Chairman
2016
DA
Dag Arne Wivelstad
Board of Directors
Board of Directors
2016
AA
Aslak Aslaksen
Board of Directors
Board of Directors
2016
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Schjøsus Invest As
Company
33.8%
33.8%
2025
Kag As
Company
29.05%
29.05%
2025
Cecilia Nauclr
Company
13.58%
13.58%
2025
Wivel Invest As
Company
3.29%
3.29%
2025
A A Holding As
Company
3.07%
3.07%
2025
Grafo As
Company
2.09%
2.09%
2025
Pharmavizer Ab
Company
1.96%
1.96%
2025
Endera As
Company
1.39%
1.39%
2025
Js Holding As
Company
1.39%
1.39%
2025
Jahatt As
Company
1.27%
1.27%
2025
Jakob Hatteland Holding As
Company
1.13%
1.13%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on IMMUNOR AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network